Senores Pharmaceuticals Limited has informed the Exchange regarding Corrigendum to the Media Release submitted with the Outcome of the Board Meeting dated January 20, 2026.
SENORES · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
Senores Pharmaceuticals has submitted a corrigendum (correction) to a media release that was originally filed along with the outcome of its board meeting held on January 20, 2026. This is a procedural rectification and does not itself disclose new business, financial, or strategic information. The actual corrected content lies within the original media release or the attached corrigendum document. Investors should refer to the original board meeting outcome for the substantive decisions.
No direct impact on shareholders or stock price; this is an administrative correction to a previously filed document. Any material business changes would be reflected in the original board meeting outcome filing.